throbber
:[Jalvmarnhismin
`Pharmaceutical
`Salins/
`
`‘
`
`edited by
`Harry G. Brittain
`Discovery Laboratories, Inc.
`Milford, New Jersey
`
`MAREEL
`
`fl MARCEL DEKKER, INC.
`
`DEKKER
`
`NEW YORK - BASEL
`
`
`
`Mylan (IPR2020-00040) Ex. 1005, p. 001
`Mylan (11311202000040) EX. 1005, p. 001
`
`

`

`
`
`
`
`
`
`l? S ”2.0! M.I.T. LIBRARIES
`015$
`
`APR 2 0 2000
`.J.
`1‘
`'1
`\0 ‘
`
`
`
`RECEIVED
`
`,1 01 e a
`
`ISBN: 0-3247-0237-9
`
`This book is printed on acid-free paper.
`
`Headquarters
`Marcel Dekker, Inc.
`270 Madison Avenue. New York, NY 10016
`tel: 212—696-9000; fax: 212-685-4540
`
`Eastern Hemisphere Distribution
`-
`Marcel Dekker AG
`Hutgasse 4, Postfach 812. CH-4001 Basel. Switzerland
`tel: 44-61-261-8482; fax: 44—61—261-8896
`
`Wet-Id Wide Web
`
`http:!!www.dekker.com
`
`The publisher offers discounts on this book when ordered in bulk quantities. For more
`information, write to Special SaleslProfessional Marketing at the headquarter; address
`above.
`
`Copyright © 1999 by Marcel Dekker, Inc. All Rights Reserved.
`
`Neither this book nor any part may be reproduced or transmitted in any form or by
`any means, electronic or mechanical, including photocopying, microfilming, and re-
`cording, or by any information storage and retrieval system, without permission in
`writing from the publisher.
`
`Current printing (last digit):
`10
`9
`8
`7
`6
`5
`4
`3
`
`2
`
`1
`
`PRINTED IN THE UNITED STATES OF AMERICA
`
`Mylan (IPR2020-00040) Ex. 1005, p. 002
`Mylan (11311202000040) EX. 1005, p. 002
`
`

`

`126
`
`130
`130
`
`132
`135
`
`141
`142
`145
`155
`
`161
`162
`163
`
`125
`
`4 S
`
`tructural Aspects of Hydrates
`and Solvates
`
`Kenneth R. Morris
`
`Purdue University
`West Lafayette, Indiana
`
`1. PHARMACEUTICAL IMPORTANCE OF CRYSTALLINE
`-HYDRATES
`
`II. HYDRATE THERMODYNAMICS
`
`A. Classical Higuchil’Grant Treatment
`B.
`Similarities and Differences Between Polymorphs and
`Hydrates
`C. Hydrogen Bonding in Hydrates
`
`HI. CLASSIFICATION OF HYDRATES
`
`A. Class 1: Isolated Site Hydratcs
`B. Class 2: Channel Hydrates
`C. Class 3: Ion Associated Hydrates
`
`IV. DEHYDRATIONIHYDRATION KINETICS
`
`A. Dehydration and Hydrate Class
`B.
`Impact of Particle Size and Morphology
`
`
`
`Mylan (IPR2020-00040) Ex. 1005, p. 003
`Mylan (11311202000040) EX. 1005, p. 003
`
`

`

`126
`
`'
`
`Morris
`
`V. BEHAVIOR OF HYDRAT'ES DURING PROCES SING
`HANDLING, AND STORAGE
`A. Processing Induced Transitions
`B. Transitions in the Final Product
`C. Kinetics of Transformation
`VI. SUMMARY
`
`REFERENCES
`
`167
`167
`173
`177
`178
`
`179
`
`l.
`
`PHARMACEUTICAL IMPORTANCE OF
`CRYSTALLINE HYDRATES
`
`The potential pharmaceutical impact of changes in hydration state of
`crystalline drug substances and excipients exists throughout the devel-
`opment process. The behavior of pharmaceutical hydrates has become
`the object of increasing attention over the last decade, primarily due
`(directly or indirectly) to the potential impact of hydrates on the devel-
`opment process and dosage form performance. Substances may
`hydrate/dehydrate in response to changes in environmental condi-
`tions, processing, or over time if in a metastable thermodynamic. state
`[1].
`
`It may not be practical or possible to maintain the same hydrate
`isolated at the discovery bench scale synthesis during scale-up activities
`for a hydrated compound. The choice of counterions to produce a more
`soluble salt form may also be dictated by the extent and type of hydra-
`tion observed for a given salt and/or by the moisture level that may
`be safely accommodated by the dosage form [2].
`The physicochemical stability of the compound may raise issues
`during preformulation. Some hydrated compounds may convert to an
`amorphous form upon dehydration and some may become chemically
`labile. This is true of cephradinedihydrate that dehydrates to become
`amorphOus and undergoes subsequent oxidation. Other compounds
`may convert from a lower to a higher state of hydration yielding
`
`Mylan (IPR2020-00040) Ex. 1005, p. 004
`Mylan (11311202000040) EX. 1005, p. 004
`
`
`
`

`

`Structural Aspects of Hydrates and Solvates
`
`127
`
`forms with lower solubility. In any case, the resulting “new” forms
`would represent unique entities that, depending on the dosage form,
`might have to be maintained throughout the manufacturing process and
`in the clinic and would impact on the regulatory status of the com«
`pound. Most often this demands that the form (usually crystalline) be
`identified and characterized with respect to handling conditions during
`the early pro-IND stage of the development process.
`As dosage form development proceeds, changes in hydration state
`can result in variable potencies depending on handling conditions dur-
`ing weighing steps, the kinetics of the hydration!dehydration process,
`and the envirorirnental conditions during processing. Differences in
`powder flow can result from changes in crystal form and/or morphol-
`ogy that may accompany the hydrationfdehydration process. This can
`affect content uniformity in solid processing either in the mixing pro-
`cess or during transfer to other processing equipment such as tablet
`presses. Aqueous granulation, particle size reduction, film coating, and
`tablet compression all provide opportunities to “trap" a compound in
`a metastable form that may “relax” to a more stable form at some
`unpredicted point in the life of a dosage form. Alternately, a kinetically
`favored but themodynarnically unstable form may be convened during
`these processes to a more stable and less soluble form.
`‘
`During and after manufacturing, moisture from the environment
`or that sealed in the package may redistribute throughout the dosage
`form and change the hydration state(s). These changes can, in turn.
`visit the negative consequences discussed above for the bulk drug on
`the dosage form. These can be manifest as changes in tablet/capsule
`dissolution rates (and perhaps bioavailability), changes in lyophile re-
`constitution times, tablet capping, chemical instability, discoloration,
`and more. Of course, the potential for changes in hydration state also
`exists for many pharmaceutical excipients (such as lactose or magne—'
`siurn stearate).
`Such problems are typically magnified as both synthetic and dos-
`age form production is scaled up. This may be caused by solvent limita-
`tions, heat transfer differences in production equipment, changes in raw
`materials and/or raw material suppliers, changes in processing times,
`and time and control constraints on product storage, to name a few.
`
`
`
`1..
`
`Mylan (IPR2020-00040) Ex. 1005, p. 005
`Mylan (IPR2020-00040) EX. 1005, p. 005
`
`

`

`
`
`
`
`~
`
`128
`
`-
`
`Morris
`
`The arguments just provided detail the potential issues around
`hydrates in the development process. The other consideration is the
`frequency with which hydrates are encountered in real life. Focusing
`on active drug substances, it is estimated that approximately one-third
`of the pharmaceutical actives are capable of forming crystalline hy-
`drates [3]. A search of the Cambridge Structural Database (CSD) shows
`that approximately 11% of all the reported crystal structures contain
`molecular water [4]. This represents over 16,000 compounds. If organ-
`ometallic compounds are excluded, this number drops to approximately
`6,000 [3.8%], and the breakdowu of these according to hydration num-
`ber is shown in Fig. 1. This shows the expected trend in which monohy-
`drates are most frequently encountered, and where the frequency de—
`creases almost exponentially as the hydration number increases. The
`hemihydratc stoichiometry occurs approximately as frequently as the
`Irihydrate, which should serve as a caution to explore fully the occur-
`rence of fractional hydration. That is, an apparent stoichiometry of 0.6
`water molecules could be a‘rpartially dehydrated monohydrate, or it
`
`3500
`
`SD00
`
`33%
`NUMBEROFOCCURENCES S
`
`cm
`
`
`
`
`HYDFlA‘I'iDN HUME ER
`
`Fig. 1 Occurrence of various crystalline hydrate stoichiometries.
`
`Mylan (IPR2020-00040) Ex. 1005, p. 006
`Mylan (11311202000040) EX. 1005, p. 006
`
`

`

`Structural Aspects of Hydrates and Solvales
`
`129
`
`could be a hernihydrate with additional sorption due to defects or amor-
`phous material.
`.
`The symmetry of these hydrate crystals follows fairly closely with
`that reported for organic structures overall [5]. Table 1 shows the break—
`down for space groups, organized by crystal system, accounting for
`the top approximately 90% of the structures. leic (number 14) is the
`most common space group here as with the general population of or-
`ganic molecules contained in the CSD. It has been reported for inor-
`ganic species that hydrated structures are generally of lower symmetry
`than are their anhydrous counterparts [6]. This is attributed to the fact
`that the highest symmetry associated with the water molecule is C1,,
`and most inorganic structures are of higher symmetry. This is not obviw
`ously the case for organic structures. Regardless of the solvation state,
`organic molecules generally exhibit lower symmetry than do inorganic
`compounds, so the impact of the symmetry constraints imposed by wa-
`ter does not appear to be the controlling element. Further comparisons
`would he required to explore the phenomena fully.
`
`Space Groups for the Top 90% of Organic
`Table 1
`Crystalline Hydrates in the Cambridge Structural
`Database
`
`Percent
`
`Space group
`Crystal system
`occurrence
`
`-
`
`15.5
`Tricliuic
`P_.
`2.6
`Triclinic
`P1
`23.2
`Monoclinic
`PM
`l3.4
`Monoclinic
`P21
`53
`Monoclinic
`C are
`2.8
`Monoclinic
`C2
`17. 8
`OI'thOI'hOInb iC
`P2|2|21
`2.3
`Orlhorhombic
`PM
`1.8
`Orthorhombic
`PM;
`1.8
`Orthorhombic
`PM
`1.3
`Orthorhombic
`Puma
`
`UnknoWn 1 2
`
`
`
`Mylan (IPR2020-00040) Ex. 1005, p. 007
`Mylan (11311202000040) EX. 1005, p. 007
`
`

`

`130
`
`Morris
`
`ll. HYDHATE THERMODYNAMICS
`
`The equilibrium thermodynamics of stoichiometric hydrates has been
`described by several authors. The overview presented here is intended
`both to review the basic thermodynamics of crystalline hydrate
`formationfstability and to highlight the intrinsic differences between
`polymorphic systems and hydrate systems (a discussion of the kinetics
`of dehydration)r hydration will be given in Section IV). The following
`description is a hybrid based on the work of Grant and Higuchi [7]
`and that of Carstensen [8].
`-
`
`A. Classical nguchiIGrant Treatment
`
`The equilibrium betWeen a hydrate and an anhydrous crystal (or be-
`tween levels of hydration) may be described by the following relation-
`ship.
`
`A(solid) + mHgO :A - mH10[solid)
`where
`
`(1)
`
`_ a[A - mHgO{SOLid)]
`Kh — ————
`a[A(solid)]a[H;O]’"
`
`Here tr represents the activity of the hydrate (aEA - mH20(solid)]} and
`anhydrate
`(a[A(solid)]),
`respectively.
`_ When the water
`activity
`(flU‘IzOD is greater than the ratio
`
`a[A - mH20(solid)]
`
`a [A (solidflifl ”a
`
`(2)
`
`then the hydrate species is the stable form. The anhydrate species will
`be stable if the water activity is less than the ratio in Eq. (2). If the
`pure solids are taken as the standard states for the hydrate and anhy-
`drous materials (i.e., as the states with unit activity),
`then K, =
`a[I-I20]"'" (and m = 1 for a monohydrate). So, clearly, the stability of
`a hydrate relative to the anhydrate (or lower hydrate) depends upon
`the activity of water in the vapor phase, or the partial vapor pressure
`or relative humidity (the ratio of the vapor pressure of water to the
`saturation vapor pressure at that temperature PIPO). This straightfor-
`ward thermodynamic description of hydrate equilibria is the key to un-
`
`Mylan (IPR2020-00040) Ex. 1005, p. 008
`Mylan (11311202000040) EX. 1005, p. 008
`
`
`
`

`

`Structural Aspects of Hydrates and Solvates
`
`131
`
`derstanding not only the stability of hydrated forms but the inherent
`differences between hydrates and polymorphs.
`Just as the state of hydration depends upon the water vapor activ—
`ity, so will the water activity {relative humidity, RH) in a closed system
`depend upon the state of hydration of the solid phase. These microenvi-
`ronmental RH values can be of significance for the redistribution of
`moisture within a dosage form and! or package. An excellent illustra~
`tion of this was given by Carstensen for sodium phosphate [9]. Figure
`2 shows the relation between water vapor pressure (P) and the number
`of moies of water for the compound. Here it is seen that as water is
`added to a closed system, the compound takes it up until it no longer
`has any capacity in a given form (i.e., all of the solid is converted to
`a given hydrate). During this time, however, the RH of the system is
`constant. As more water is added, the RH rises until the critical value
`is reached that is sufficient to initiate the formation of the next higher
`
`hydration state. This cycle repeats as long as there are more states to
`be attained. Ultimately, the RH drifts up if the compound dciiquesces.
`One would not, therefore, expect to maintain a constant RH with differ-
`ences in water content in a system unless it contains hydratable compo-
`nents to buffer the changes. The type of behavior shown here is most
`common with inorganic compounds, but the principle is the same for
`
`(in! a
`
`
`
`MO
`
`.5O %Water(9water/0.019Solid)
`
`ll
`
`20
`
`40
`
`SD
`
`30
`
`100
`
`'56 Relative Humidity
`
`Fig. 2 Vapor pressure—hydration state diagram of sodium phosphate (repro-
`duced with permission).
`
`Mylan (IPR2020-00040) Ex. 1005, p. 009
`Mylan (IPR2020-00040) EX. 1005, p. 009
`
`
`
`

`

`132
`
`Morris
`
`organic molecules even though the number of stable hydrates that form
`may be less.
`
`B. Similarities and Differences Between Polymorphs '
`and Hydrates
`
`Hydrates and polymorphs are typically discussed together (as in this
`volume), and there are good reasons for this. In the scope of character—
`ization of pharmaceuticals, many of the behaviors of polymorphic sys-
`tems are at least apparently shared by compounds that can exist in vari-
`ous crystalline states of hydration. For the purposes of this chapter,
`such systems (including the anhydrous) will be referred to simply as
`hydrates. Members of both polymorphic and hydrate systems have dif—
`ferent crystal structures and exhibit different x-ray powder diffraction
`patterns (XRPD), thermograms (DSC or TGA), infrared spectra, disso«
`lution rates, hygroscopicity, etc. luterconversion between polymorphs
`or hydrates may occur as a‘function of temperature andt'or pressure or
`be solution mediated. The potential for interconversion during pro-
`cessing, stability testing, and storage is,
`therefore, present for both
`polymorphs and hydrates. Given this long list of similar behaviors, it
`is generally proper mat polymorphs and hydrates be addressed in the
`same general area of the pharmaceutical development process (for both .
`technical and regulatory concerns).
`The differences between polymorphs and hydrates are significant.
`The basis for all these differences is that polymorphs are different crys-
`tal structures of the same moleculcs(s) while hydrates are crystals of the
`drug molecule with different numbers of water molecules. As discussed
`above, the hydration state (and therefore the structure) of a crystalline
`hydrate is a function of the water vapor pressure (water activity) above
`the solid. Polymorphs, however, are typically only affected by changes
`in water vapor pressure if water sorption allows molecular motion,
`which in turn allows a reorganization into a different polymorph (Le,
`a solution mediated transformation). This distinction is particularly im-
`portant in defining the relative free energy of hydrates. A simple (only
`one molecule) anhydrous crystalline form is a one component system,
`and the free energy is, practically, specified by temperature and pres—
`sure. A crystalline hydrate is a two—component system and is specified
`
`Mylan (IPR2020-00040) Ex. 1005, p. 010
`Mylan (11311202000040) EX. 1005, p. 010
`
`
`
`

`

`Structural Aspects of Hydrates and Solvates
`
`133
`
`by temperature, pressure, and water activity. In both cases it is assumed
`that the activity of the pure solid is unity.
`Consider the thermodynamic stability of a phase that crystallizes
`from water. If the phase is anhydrous (assuming no specific interaction
`between the molecule and the water), when the phase is removed from
`the solvent it is usually stable at that temperature (i.e., the free energy
`of the phase is independent of the solvent of origin). If the phase is
`hydrated, when it is removed from the solvent the situation changes
`completely. All that can be known is that the phase was thermodynami-
`cally stable at a water activity of approximately unity. Although it is
`a rule of thumb that the higher the hydration state that forms at a tem-
`perature the more thermodynamically stable, Grant et a1. [10] have re-
`ported the opposite behavior. Once removed from the water, the activity
`of water needed to maintain the form (the critical activity) had to be
`determined by other methods. These may include water vapor sorption
`data or a titration of the amount of water in a cosolvent system [111.
`A typical constant pressure G—T diagram (free energy vs. temperature,
`recalling that SGIST = #5) for a polymorphic system is really analo-
`gous to a logarithm solubility vs. reciprocal temperature plot (in X vs.
`1/2“) for a system of hydrates (Figs. 3a and h). Alternatively, a 6—1"
`plot for a hydrate system at constant water activity is analogous. The
`relationship between free energy and the ideal solubility of a solid is
`seen from the following equation.
`
`AG=rRT1nX
`
`(3)
`
`or
`
`mx=m_mt
`R
`R
`T
`
`where ASf and um are the entropy and enthalpy of fusion at the melting
`point, respectively, and R is the gas constant. A plot of in X against
`If T should yield a straight line with a negative slope equal to —AHfr’R'
`and an intercept of ASffR for each phase. This conclusion assumes that
`the enthalpy of solution is equal to the enthalpy of melting at the melt-
`ing point. A more general expression may be derived, but the reciprocal
`dependence of solubility and temperature is preserved. Just as with a
`
`
`
`Mylan (IPR2020-00040) Ex. 1005, p. 011
`Mylan (11311202000040) EX. 1005, p. 011
`
`

`

`134
`
`Morris
`
`(0}
`
`Temperature
`
`
`ANHYDROUS
`
` %
` 0 w
`
`TRIHYDRATE
`
`
`
`LOGD.R.,ngmIJrninJcm.1x1!]2 D
` O N
`
`D
`
`(b)
`
`3.2
`
`3.3
`1IT>< 101
`
`3.4
`
`(a) G-T diagram, two polymorphs. temperature plot. (b) Log dissolu-
`Fig. 3
`tion vs. reciprocal temperature plot for ampiciliin anhydrate and trihydrate
`(reproduced with permission).
`
`G—T plot, the intersection of curves generated for two' different crystal-
`line phases represents a point of equal free energy and a transition tem-
`perature.
`
`There are many implications of the relatively more complex struc-
`ture of hydrates. As water is included or lost from the crystal structure,
`there must be a change in the volume of the unit cell [corrected for Z,
`the number of molecules per unit cell) at least as large as the volume
`
`
`
`Mylan (IPR2020-00040) Ex. 1005, p. 012
`Mylan (11311202000040) EX. 1005, p. 012
`
`

`

`Structural Aspects of Hydrates and Solvates
`
`135
`
`of the water molecule (15—40 21.3) [12]. Although there is no study
`known to the author comparing the relative volume change between
`polymorphic pairs vs. hydrate pairs, it must be assumed that the trend
`would be that the volume change is larger for hydrates, which have to
`accommodate the additional volume occupied by the water molecules.
`The obvious problem for pharmaceutical development is that the
`water activity can vary throughout the lifetime of the compound, and _
`it is for this reason that knowledge of the water sorption behavior of
`active substances and excipients is so critical.
`
`C. Hydrogen Bonding in Hydrates
`The ability of water to form hydrogen bonds and hydrogen bonding
`networks gives it unique behavior with respect to colligative properties
`such as boiling and melting points. Similarly, hydrogen bonding be-
`tween water molecules and drug molecules in the solid state dictates
`its role in the structure of all classes of crystalline hydrates lie, the
`ability of water to form cocrystals with the drug molecule). Water will,
`of course, be hydrogen bonded whenever physically possible. This may
`take the form of hydrogen bonding to other water molecules, with func-
`tional groups on other molecules, or to anions. Hydrogen bonding to
`other water molecules is common both in the crystal lattice and in inter-
`stitial cavities or channels. Hydrogen bonding to other moieties and
`anions in crystalline hydrates is primarily within the lattice. In addition,
`the lone pair electrons of the water oxygen may be associated with
`metallic cations present in many salts. This interaction is largely elec-
`trostatic in nature for the metal cations common to pharmaceutics (Na,
`Ca, K, Mg). These main-group metal ions lack the d-orbitals of suitable
`energy that are necessary to form coordinate covalent or coordination
`bonds that ions of the transition series form with oxygen. It is often
`stated that MgGI) has a coordination number of 4, but this is a result of
`packing (or geometric) restrictions arising when fitting water molecules
`around the cation in response to the electrostatic attraction. Since these
`“bonds" are mostly electrostatic in nature, they are not properly de-
`scribed hy a molecular orbital but are best defined by classical electro-
`statics [13]. These “bonds” are often stronger than hydrogen bonds
`but exist with less directional dependence. A typical water hydrogen
`
`
`
`Mylan (IPR2020-00040) Ex. 1005, p. 013
`Mylan (IPR2020-00040) EX. 1005, p. 013
`
`

`

`136
`
`Morris
`
`bond is on the order of 4.5 kcalirnol, whereas a sodium—oxygen lone
`pair electrostatic interaction can be four to five times stronger. These
`bonds also exert their influence through hydrogen bonds in the form
`of cooperative effects. The specific characteristics of the hydrogen bond
`are presented here in the formalism of Falk and Knop [6].
`The ubiquitous hydrogen bonding of water is largely a result of
`its being both a hydrogen bond donor and acceptor. It may participate
`in as many as four hydrogen bonds, one from each hydrogen and one
`for each lone pair on the oxygen. Classification schemes based solely
`on the type of coordination of the water oxygen have been proposed
`{6]. As each bond is formed, it makes the other sites more attractive
`as partners for additional bonds. Hydrogen bond acceptors must be
`electronegative and include one of the following: oxygen atoms from
`other water molecules, oxygen and nitrogen atoms from other func-
`tional groups, and chlorine atoms. Hydrogen bond donors include pro-
`tons on nitrogen, oxygen,. and sulfur, of the types usually found on
`water, alcohols, amines, and‘the like.
`..
`'
`Free water (vapor) has an OH bond length of 0.957 A and an
`HOH angle of 10452". As soon as the molecule starts interacting with
`other molecules through hydrogen bonds, coordination, or other elec-
`trostatic “bonds", the molecule is distorted from its free conformation.
`The formation of hydrogen bonds weakens the OH bond, usually re;
`sulting in an increase in its length. This increase can be up to 0.01 A
`for an exceptionally strong hydrogen bond, but it is more typically on
`the order of 0.01 to 0302 A for organic hydrates with hydrogen bond
`lengths of 2.7 to 2.9 A (0—0 distance).
`The limits of length of a hydrogen bond are defined at the lower
`end by the van tier Waais radii of the two atoms and at the upper end
`arbitrarily by the length of the weakest hydrogen bond observed. This
`can be seen more quantitatively by expressing the hydrogen bond dis-
`tances showu in Fig. 4 in terms of the van der Waals radii.
`
`R(H—Y) < r(H) + r(Y) — 0.20 .31
`
`'
`
`(4)
`
`and since r(H") = 1.2 11,
`
`R(H——Y) < r(Y) — 1.00 A
`
`Mylan (IPR2020-00040) Ex. 1005, p. 014
`Mylan (11311202000040) EX. 1005, p. 014
`
`
`
`

`

`
`
`Structural Aspects of Hydrates and Solvates
`
`137
`
`H
`
`\ r(O-H)
`
`0.“ ‘
`
`H gr
`
`rot?)
`
`K‘ Y
`
`Fig. 4 Formalism used in the discussion of hydrogen bond strength and
`length. (From Ref. 6.)
`
`The factor of 0.2 represents the combined experimental and statistical
`uncertainty. The compounds studied by Fallc and Knop were inorganic
`and small organic hydrates [6]. 0f the 129 compounds studied, only
`one failed this criterion. Often the hydrogen bond lengths are given as
`the O—Y (e.g., oxygenuoxygen or oxygen—chlorine) distances, be-
`cause in x-ray diffraction studies it is often difficult or impossible to
`locate accurately the hydrogen atoms due to their inherently low scat-
`tering and their relatively high mobility. Because of the large cross
`sections, hydrogen atoms are often located by neutron diffraction stud-
`ies. Under these circumstances. crystallographers will report the O—Y
`distance they know to be reliable, and geometric constraints may also
`be applied to such data.
`
`R[0r~Y) s ROI—Y) + r(OH)
`
`(5)
`
`substituting above, then setting r(OH) = 0.98 13.,
`
`R(O—Y) 5 r{Y) + 1.93 it
`
`As the electrostatic bond strength of the donor to the water oxygen (X)
`increases, the length of the H—Y bond decreases. This cooperative
`effect is also seen as the number of hydrogen bonds per water molecule
`increases. Hydrogen bonds prefer to be linear but may adopt a range
`of angles at the expense of the strength of the bond [6,15].
`All of these aspects of water hydrogen bonding are evident in
`the infrared spectra of crystalline hydrates. When a molecule absorbs
`
`
`
`Mylan (IPR2020-00040) Ex. 1005, p. 015
`Mylan (11311202000040) EX. 1005, p. 015
`
`

`

`138
`
`Morris
`
`infrared radiation, this energy is used to excite the molecule into higher
`vibrational energy level states. The occupancy of these higher states
`manifests itself in greater degrees of molecular Vibration. The frequen-
`cies at which the molecule absorbs are a function of the mass of the
`bonded atoms, the geometry of the molecule, and the force constant
`(strength) of the bond. This relationship can be described by analogy
`to classical mechanics through Hooke‘s law, which states that the fre—
`quency of motion (v) for a harmonic oscillator is inversely proportional
`to the square root of the reduced mass of the system (it). The force
`constant (f, in units of dynr'cm) is the proportionality constant. Thus
`
`
`1
`
`V = one) (El
`
`f
`
`If:
`
`(6)
`
`where c is the velocity of light in units of cm/s. As illustrated in Fig.
`5, Water in crystalline hydrates has nine potential degrees of freedom:
`two stretching modes (symmetric and asymmetric), one bending mode,
`three vibrational modes (hindered rotation), and three hindered transla-
`
`ii
`;
`\0/
`i
`a
`
`\H
`H;
`\0/
`i
`b
`
`H;
`\H
`\/
`#0
`C
`
`+
`H
`
`+
`H
`
`+
`H
`
`.
`H
`
`I
`H
`
`1-!
`
`Fig. 5 Vibrational modes of water. Shown are the internal modes: (a) sym-
`metric stretch, (b) bending, (c) asymmetric stretch. and the librational modes
`(d) wag, (e) twist, and (f) rock. Not shown are the three hindered translational
`modes.
`
`Mylan (IPR2020-00040) Ex. 1005, p. 016
`Mylan (11311202000040) EX. 1005, p. 016
`
`
`
`

`

`Structural Aspects of Hydrates and Sotva’tes
`
`139
`
`tional modes. These vibrational modes and their characteristic absorp-
`tion frequencies are presented in Table 2 and contrasted with those of
`water vapor.
`The dominant feature in the infrared Spectrum of a hydrate is band
`system associated with the OH stretching frequencies between 4000
`and 3000 cm“. These peaks are unusually intense due to the effect of
`hydrogen bonding on the changes in dipole moment that are associated
`with the wave functions describing the molecular motion. If an O—H
`stretching band is not observed, then no water is associated with the.
`compound. When present, the contributing OH groups must be properly
`assigned to distinguish water from alcoholic, phenolic, hydroxide, or
`other interfering absorptions. This is accomplished by first assigning
`energy values to the known structure of the molecule from tables. If
`resolved, the presence of an H20 bending frequency around 1600 cm“
`is proof that the sample contains water. Comparing this to the IR spec-
`trum of the anhydrous material or the dehydrated sample shows which
`peaks in the region are due only to water. The IR spectra of ampicillin
`before and after dehydration exhibits such behavior.
`Table 2 also shows that the OH stretching frequency of water
`occurs at lower wave numbers (longer wavelength and lower energy)
`in the crystal than in the vapor. This is due to the reduction of the force
`constant (f) by interaction of the water with neighboring groups, in
`particular hydrogen bonding and lone pair interactions involving the
`water oxygen. The weakening of the bond results ip a Slight elongation
`of the bond length, in the range of 0.01 to 0.02 A [15}. This shift in
`
`Table 2 Vibrational Modes of Water in Various Phases
`_____—_—_.__——-—————-
`
`Frequency in
`vapor phase
`[cm'l]
`
`3755.8 (synunetrlc)
`365 5.7 (asymmetric)
`1594.6
`
`Frequency in
`solid phase
`(cm‘l)
`
`2850—3625
`
`Vibrational mode
`
`Stretching
`
`1498—1732
`Bending
`355—1080
`Rotationfllibration
`'
`200—490
`Translation
`__—__,__._.——-——-——-—
`
`Mylan (IPR2020-00040) Ex. 1005, p. 017
`Mylan (11311202000040) EX. 1005, p. 017
`
`
`
`

`

`140
`
`-
`
`Morris
`
`the OH stretching frequency of water can be used to evaluate the inter-
`action energy between water and the other molecules. Specifically, the
`higher is the degree of water hydrogen bonding,
`the lower the. fre-
`quency will be of the OH stretch. In fact, good correlation between
`OH stretching frequency and the length of hydrogen bonds is available
`for inorganics and very small organic crystals [14]. While repulsive
`lattice energy tends to increase this frequency, it typically yields only
`a very small shift. In large molecular crystals, however, the energetics
`become more complicated and the correlation is not as good. Adventi-
`tious adsorbed water tends to have broad peaks in the lower part of
`the frequency range. The broadening is due to the vibrational coupling
`between water molecules. and the lower frequencies are due to the mul—
`tiple hydrogen bonds. This “dispersion of stretching frequencies" is
`analogous to the broadening of DSC peaks due to the multiple energetic
`environment that adventitious water can experience. If the water occu—
`pies only one type of crystal site, the DSC and IR peaks should be
`sharp relative to those of adventitious water. This is seen in the ampicil-
`lin example of the classification section. The 0—H stretching peaks
`from water in the crystal lattice will occur at various frequencies de
`pending upon the strength of the hydrogen bonding.
`In addition to shifts in frequency and peak shape, peaks may be-
`come split owing to the interaction of the two water hydrogens if they
`participate in different hydrogen bonds. Therefore in some crystalline
`hydrates there may be two or more peaks associated with the OH
`stretching mode.
`Metal cations affect the infrared absorption behavior in several
`ways. First, if the water oxygen is bound at the inner hydration sphere
`of the cation, polarization of the electron density causes stronger hydro-
`gen honds to be formed. This effect will lower the OH stretching fre-
`quency in a manner proportionate to the degree of bond strengthening,
`a decrease that can be up to 640 cm“1 in inorganic compounds [6,15].
`Second, cation—water interaction can increase the bending frequencies
`(which are observed in the 1600 cm‘1 region) by as much as 50 cm“.
`Finally, the bonds formed betWeen the cation and the atoms in its inner
`
`coordination sphere will be observed as low-frequency modes below
`400 cm".
`
`Mylan (IPR2020-00040) Ex. 1005, p. 018
`Mylan (11311202000040) EX. 1005, p. 018
`
`
`
`

`

`
`
`
`
`Structural Aspects of Hydrates and Solvates
`
`141
`
`III. CLASSIFICATION OF HYDRATES
`
`The combination of the vibrational mode information, the hydrogen
`bonding characteristics, and the thermodynamic relationships serves to
`form a clear picture as to why water can and does participate in hydrate
`formation with drug molecules. The possible structures that may result
`from such interactions are quite diverse. For practical purposes, an
`identification of types or classes of possible resulting structures is use-
`ful. Water is small enough to fill many commonly occurring periodic
`“voids" formed when larger molecules are packed, and it interacts
`through hydrogen bonds to overcome some of the entropy of mixing.
`The ability of the water molecules to self-associate. combined with the
`small size, allows them to fill larger periodic spaces conforming to
`different shapes. The characteristics give water a chameleon-like qual-
`ity (also seen in protein hydration). which gives rise to “motifs” of
`water arrangements in crystal structures.
`Crystalline hydrates have been classified by either structure or
`energetics [6]. The idea of the structural classification scheme presented
`here is to divide the hydrates into three classes that are discernible
`by the commonly available analytical techniques. The classification of
`crystalline hydrates of pharmaceutical interest by their structural char-
`acteristics is the most common, intuitive, and usefui approach. A good
`classification system should direct the prefonnulation/formulation sci—
`entist to the characteristics of the particular class that will help in identi-
`fying a new s

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket